Bull Of The Day: Ohr Pharma

The last earnings estimate revision for the current year saw EPS loss shrink from $1.18 to $1.06. What’s been a big shot in the arm has been a couple of huge earnings beats over the last two quarters.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.